WallStreetZenWallStreetZen

NASDAQ: AVDL
Avadel Pharmaceuticals PLC Stock Ownership - Who owns Avadel Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Avadel Pharmaceuticals PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas S. McHughChief Financial Officer2024-01-162,000$14.50
$29.00kBuy
Mark Anthony McCamishDirector2023-12-2875,000$14.53
$1.09MSell
Thomas S. McHughChief Financial Officer2023-08-142,000$14.45
$28.90kBuy
Mark Anthony McCamishDirector2023-08-1128,975$14.93
$432.63kSell
Gregory J. DivisChief Executive Officer2023-08-1010,000$13.20
$132.00kBuy
Geoffrey Michael GlassDirector2023-08-1014,000$13.40
$187.60kBuy
Eric J. EndeDirector2023-05-1813,000$13.93
$181.10kBuy
Linda PalczukDirector2023-05-092,500$14.76
$36.90kBuy

1 of 1

AVDL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVDL insiders and whales buy or sell their stock.

AVDL Shareholders

What type of owners hold Avadel Pharmaceuticals PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC12.28%11,125,330$196.47MInstitution
Rtw Investments LP7.67%6,947,918$122.70MInstitution
Polar Capital Holdings PLC7.45%6,751,782$119.24MInstitution
Gendell Jeffrey L6.20%5,615,350$99.17MInstitution
Broadfin Healthcare Master Fund Ltd4.56%4,133,464$73.00MInsider
Vivo Capital LLC4.52%4,096,428$72.34MInstitution
James E. Flynn4.06%3,674,506$64.89MInsider
Kevin Kotler3.46%3,130,573$55.29MInsider
Wealth Effects LLC2.67%2,416,326$42.67MInstitution
Woodline Partners LP2.05%1,852,412$32.71MInstitution

1 of 3

AVDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVDL61.94%14.34%Net Selling
SUPN45.35%54.65%Net SellingNet Selling
TARO12.90%50.73%
DVAX71.63%28.37%Net SellingNet Selling
EVO3.20%0.00%
View Top Pharmaceutical Stocks

Avadel Pharmaceuticals Stock Ownership FAQ

Who owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals (NASDAQ: AVDL) is owned by 61.94% institutional shareholders, 14.34% Avadel Pharmaceuticals insiders, and 23.72% retail investors. Broadfin Healthcare Master Fund Ltd is the largest individual Avadel Pharmaceuticals shareholder, owning 4.13M shares representing 4.56% of the company. Broadfin Healthcare Master Fund Ltd's Avadel Pharmaceuticals shares are currently valued at $73.66M.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.